Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Bitcoin’s Network Strength Hits Historic High Amid Price Stability

Felix Baarz by Felix Baarz
September 4, 2025
in Bitcoin, Blockchain, Crypto Stocks
0
Bitcoin Stock
0
SHARES
227
VIEWS
Share on FacebookShare on Twitter

Bitcoin’s price may be experiencing a period of consolidation, but beneath the surface, its underlying network is demonstrating unprecedented strength. The blockchain has shattered a significant technical barrier, with its average hash rate sustainably exceeding 1 zettahash per second (ZH/s) for the first time in history. This monumental achievement highlights a powerful trend of increasing computational security, raising questions about its potential impact on the cryptocurrency’s future valuation.

Unprecedented Security and Upcoming Difficulty Adjustment

The network’s seven-day average hash rate consistently surpassed the 1 ZH/s threshold in early September 2025, after only briefly touching this level previously. Current data indicates the processing power has climbed even higher to approximately 1.279 ZH/s. This sustained growth reflects continuous capital investment into mining infrastructure worldwide. Consequently, analysts project one of the most substantial mining difficulty adjustments of the year, estimated to increase by over 7%.

Long-Term Conviction Trumps Short-Term Selling Pressure

On-chain analytics present a compelling narrative of holder conviction that contradicts stories of widespread selling by early adopters. Investors who have held their Bitcoin for 7 to 10 years now control 8.1% of the total supply, representing the largest share since 2019. Furthermore, a significant 17% of all coins have remained dormant in the same wallets for more than a decade, with this figure continuing to trend upward, signaling profound long-term belief in the asset.

Should investors sell immediately? Or is it worth buying Bitcoin?

Institutional Participation Shows Mixed but Steady Signals

While Bitcoin exchange-traded funds (ETFs) have experienced fluctuating inflows and outflows, institutional engagement remains robust. Major traditional finance firms continue to develop and expand infrastructure for Bitcoin exposure. However, a cautious stance persists among some institutions, primarily due to uncertainty surrounding potential interest rate changes by the U.S. Federal Reserve.

Price Action and Key Technical Levels

Following recent peaks near $117,000, Bitcoin is currently consolidating within a range between $110,000 and $112,000. Market strategists have identified a crucial support band between $107,000 and $108,900. A successful defense of this zone could pave the way for a test of higher resistance levels, with price targets emerging in the $113,600 to $115,000 range.

The central question for traders is whether this record-breaking network strength can provide the necessary momentum for Bitcoin to overcome its typical seasonal weakness in September and embark on a new upward trajectory.

Ad

Bitcoin Stock: Buy or Sell?! New Bitcoin Analysis from February 7 delivers the answer:

The latest Bitcoin figures speak for themselves: Urgent action needed for Bitcoin investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Bitcoin: Buy or sell? Read more here...

Tags: Bitcoin
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Bitcoin Stock
Bitcoin

Bitcoin Plummets Amidst Widespread Market Liquidation

February 6, 2026
XRP Stock
Analysis

XRP Faces Sustained Market Pressure Amid Leverage Unwind

February 6, 2026
Next Post
DeFi Technologies Stock

DeFi Technologies Announces Major Buyback and Upgraded Outlook Following Strong Quarter

Bayer Stock

Bayer's Pharmaceutical Ambitions Suffer Major Clinical Trial Setback

Puma Stock

Puma Shares Face Downgrade as Acquisition Hopes Fade

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com